Aħbarijiet tal-Peptidi Beyond Price Cuts: What Bachem Analyst Support Discloses on Peptide Supplier Stability Aug 21, 2026 Aqra aktar
Peptidi Sintetiċi Preparing Peptide INDs for FDA Expedited Review: CMC Checklist Aug 19, 2026 Aqra aktar
Combinatorial Synthesis Translating Yeast Display Outputs to Peptide Synthesis Specs Aug 19, 2026 Aqra aktar
Servizz ta' Sintesi tal-Peptidi tad-Dwana Beyond the COA: Third-Party Peptide Testing Audit Guide Aug 11, 2026 Aqra aktar
Peptidi tad-dwana After Peptide Sciences’ Shutdown: Supplier Switching Playbook Aug 10, 2026 Aqra aktar
Produzzjoni tal-Peptidi When Papers Cite Vendor Vectors: How to Read Reagent Citations (Case Study: GenScript pcDNA3 in MDM2 Research) Aug 6, 2026 Aqra aktar
Kimika tal-Peptidi After Peptide Sciences’ Shutdown: How Labs Should Vet Alternate BPC‑157 Suppliers Aug 6, 2026 Aqra aktar
Sinteżi tal-Peptidi Upgrading Quality Documentation in the Research Peptide Market: Lessons from NOX Peptides’ New Testing Papers Aug 3, 2026 Aqra aktar
Riżultati Tekniċi Modifika ta 'Glycosylation Fotokatalitika-Preċiża ta' Peptidi Mejju 14, 2025 Aqra aktar
